Photo from wikipedia
Implantable cardioverter-defibrillator (ICD) implantation has been one of the milestones in the treatment of heart failure providing a significant survival benefit. Current guidelines recommend that patients who have a sustained… Click to show full abstract
Implantable cardioverter-defibrillator (ICD) implantation has been one of the milestones in the treatment of heart failure providing a significant survival benefit. Current guidelines recommend that patients who have a sustained low left ventricular ejection fraction (LVEF) of 35% or less should be evaluated for ICD for primary prophylaxis (P-ICD). Our study aimed to investigate the use of P-ICD and associated outcomes in Jacobi Medical Center, a municipal New York City public teaching hospital serving an inner-city patient population located in Bronx, NY.
Journal Title: Journal of General Internal Medicine
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!